Michael Kornberg
Child & Adolescent Psychiatry · San Diego, CANPI 1174786834
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 391 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,044 and has fallen 60.9% since, to $800 in 2025. Among child & adolescent psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 391 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$2K
- AbbVie$1K
- Ironshore Pharmaceuticals Inc.$805
- Bausch Health US, LLC$794
- Supernus Pharmaceuticals, Inc.$772
- Takeda Pharmaceuticals U.S.A., Inc.$623
- plus $2K from 12 others
What the payments were for
- Food & beverage$7,282100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 118 | $1,620 |
| AbbVie(2 entities) | 50 | $1,008 |
| Ironshore Pharmaceuticals Inc. | 41 | $805 |
| Bausch Health US, LLC | 37 | $794 |
| Supernus Pharmaceuticals, Inc. | 23 | $772 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $623 |
| Otsuka America Pharmaceutical, Inc. | 30 | $512 |
| Johnson & Johnson | 18 | $362 |
| Vanda Pharmaceuticals Inc. | 10 | $265 |
| Shire North American Group Inc | 19 | $178 |
| Corium, LLC | 3 | $84 |
| Tris Pharma Inc | 4 | $80 |
| Arbor Pharmaceuticals, Inc. | 3 | $52 |
| Neurocrine Biosciences, Inc. | 4 | $50 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$121
How this compares
$7,283 in reported general payments places this provider in the 95th percentile of 434 child & adolescent psychiatry providers in California.
See all child & adolescent psychiatry providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 13 | $6,858 |
| Clozapine OdtClozapine | 13 | $5,516 |
| TrintellixVortioxetine Hydrobromide | 12 | $5,499 |
| ConcertaMethylphenidate Hcl | 12 | $5,028 |
| Bupropion XlBupropion Hcl | 15 | $736 |
| Buspirone Hcl | 15 | $470 |
| Mirtazapine | 17 | $317 |
| Fluoxetine Hcl | 12 | $266 |
| Paroxetine Hcl | 12 | $257 |
| Risperidone | 30 | $202 |
| Sertraline Hcl | 18 | $178 |
| Guanfacine Hcl | 12 | $176 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $171 |
| Benztropine Mesylate | 16 | $163 |
| Escitalopram Oxalate | 16 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $623 | $5,49912 claims |
| Johnson & JohnsonConcerta | $362 | $5,02812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 434 child & adolescent psychiatry providers in California.
Other child & adolescent psychiatry in San Diego
- Ellen HeynemanSan Diego$62K
- Michael McManusSan Diego$15K
- Kevin CoxOjai$2.9M
- Sukhjit BrarFresno$283K
- Manpreet SinghSacramento$104K
- Ihab SolimanCorona del Mar$93K
- Syed NaqviLos Angeles$69K
- Mark McDonaldLos Angeles$31K
- James HartmanDanville$21K
- Mohsin KhaliqueSan Ramon$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.